EIF2AK2 and neoplasm: Among the four ISR arms, the PKR/eIF2α-P arm exhibits anti-tumor effects downstream of interferons, tumor suppressors like the phosphatase and tensin homolog (PTEN) and P53, or after treatments with chemotherapeutic drugs9–15.